Multi-Mechanistic Hepatoprotective Effects of Montelukast Against Doxorubicin-Induced Liver Injury in Rats
Open Access
- 30 September 2026
- journal article
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 9 (3) , 621-631
Abstract
Aim: Despite its antineoplastic effect, doxorubicin (DOX) causes significant oxidative stress and cellular damage in the liver. This study aimed to demonstrate the oxidative damage induced by DOX in liver tissue at the biochemical, histological, and molecular levels and to evaluate the protective effects of Montelukast (ML) on this damage. Material Method: To further evaluate the oxidative stress induced by DOX in liver tissue, superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) activities, reduced glutathione (GSH) levels, and malondialdehyde (MDA) levels were analyzed (pKeywords
Funding Information
- None
This publication has 24 references indexed in Scilit:
- Regulated cell death pathways in doxorubicin-induced cardiotoxicityCell Death & Disease, 2021
- Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applicationsHeart Failure Reviews, 2020
- Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosisBiomedicine & Pharmacotherapy, 2017
- Pinocembrin attenuates hippocampal inflammation, oxidative perturbations and apoptosis in a rat model of global cerebral ischemia reperfusionPharmacological Reports, 2015
- Montelukast, a Cysteinyl Leukotriene Receptor-1 Antagonist Protects Against Hippocampal Injury Induced by Transient Global Cerebral Ischemia and Reperfusion in RatsNeurochemical Research, 2014
- Doxorubicin‐Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to CardiomyopathyMedicinal Research Reviews, 2013
- Protective Effect of Montelukast, a Cysteinyl Leukotriene Receptor-1 Antagonist, against Intestinal Ischemia-Reperfusion Injury in the RatActa Chirurgica Belgica, 2013
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategiesJournal of Molecular and Cellular Cardiology, 2012
- Protective Effects of Erdosteine on Doxorubicin-induced Hepatotoxicity in RatsArchives of Medical Research, 2007
- Doxorubicin hepatotoxicity and hepatic free radical metabolism in ratsToxicology, 2005